Papers: 10.18632/oncotarget.8006

https://doi.org/10.18632/oncotarget.8006

Genomic markers of panitumumab resistance including ERBB2/HER2 in a phase II study of KRAS wild-type (wt) metastatic colorectal cancer (mCRC)

Cited by: 11
Author(s): Garrett Barry, Maggie C.U. Cheang, Hector Li Chang, Hagen F. Kennecke
Published: over 10 years ago

Software Mentions 1